StealthX — Full data
2026
Final results from the trial, including cellular immune response data, are expected later in 2026, subject to completion of the study by NIAID.Source filing
CAPRICOR THERAPEUTICS INC · Data as of 2026-09-08
2026
Final results from the trial, including cellular immune response data, are expected later in 2026, subject to completion of the study by NIAID.Source filing
2026
Final results from the trial, including cellular immune response data, are expected later in 2026, subject to completion of the study by NIAID.Source filing
Nov 22
New PDUFA target action date of November 22, 2026 follows submission of additional Phase 3 HOPE-3 data and analyses supporting a refined proposed indication –Source filing